Explore: Trastuzumab
Discover books, insights, and more — all in one place.
Learn more about Trastuzumab with top reads curated from trusted sources — all in one place.
AI-Generated Overview About “trastuzumab”:
Books Results
Source: The Open Library
The Open Library Search Results
Search results from The Open Library
1Why Not Me Mandy McMillan with Lesley Roberts
By Mandy McMillan
“Why Not Me Mandy McMillan with Lesley Roberts” Metadata:
- Title: ➤ Why Not Me Mandy McMillan with Lesley Roberts
- Author: Mandy McMillan
- Publisher: Hachette Scotland
- Publish Date: 2010
“Why Not Me Mandy McMillan with Lesley Roberts” Subjects and Themes:
- Subjects: ➤ Breast, cancer - Scotland, biography - Antineoplastic agents - Pregnancy, complications - Breast - Biography - Cancer - Patients - Trastuzumab - Cancer in pregnancy
Edition Identifiers:
- The Open Library ID: OL26156282M
- All ISBNs: 0755360583 - 9780755360581
Access and General Info:
- First Year Published: 2010
- Is Full Text Available: Yes
- Is The Book Public: No
- Access Status: Borrowable
Online Access
Downloads Are Not Available:
The book is not public therefore the download links will not allow the download of the entire book, however, borrowing the book online is available.
Online Borrowing:
- Borrowing from Open Library: Borrowing link
- Borrowing from Archive.org: Borrowing link
Online Marketplaces
Find Why Not Me Mandy McMillan with Lesley Roberts at online marketplaces:
- Amazon: Audiable, Kindle and printed editions.
- Ebay: New & used books.
2Her-2
By Robert Bazell
“Her-2” Metadata:
- Title: Her-2
- Author: Robert Bazell
- Language: English
- Number of Pages: Median: 214
- Publisher: ➤ Random House - Penguin Random House - Random House Value Publishing - Diane Pub Co
- Publish Date: 1998 - 2011
- Publish Location: New York
“Her-2” Subjects and Themes:
- Subjects: ➤ HER-2 gene - Breast - Cancer - Trastuzumab - HER-2 protein - Immunotherapy - New York Times reviewed - Breast, cancer - Cancer, treatment - Cancer, immunotherapy - Monoclonal antibodies - Breast Neoplasms - Therapy - Therapeutic use - Borstkanker - Gentherapie
Edition Identifiers:
- The Open Library ID: ➤ OL7995890M - OL358904M - OL8021273M - OL40408924M - OL7699388M - OL7585381M
- Online Computer Library Center (OCLC) ID: 39130126 - 228123684
- Library of Congress Control Number (LCCN): 98018877
- All ISBNs: ➤ 9780609000991 - 9781299024809 - 0812991842 - 0609000993 - 9780812991840 - 067945702X - 0756750199 - 9780679457022 - 9780756750190 - 1299024807
First Setence:
"One morning in the fall of 1978, Anne McNamara showed while her husband, Jeff, tended to Luke, their one-year-old son."
Access and General Info:
- First Year Published: 1998
- Is Full Text Available: Yes
- Is The Book Public: No
- Access Status: Printdisabled
Online Access
Downloads Are Not Available:
The book is not public therefore the download links will not allow the download of the entire book, however, borrowing the book online is available.
Online Borrowing:
Online Marketplaces
Find Her-2 at online marketplaces:
- Amazon: Audiable, Kindle and printed editions.
- Ebay: New & used books.
3Drugs for HER2-positive breast cancer
By Maria Sibilia
“Drugs for HER2-positive breast cancer” Metadata:
- Title: ➤ Drugs for HER2-positive breast cancer
- Author: Maria Sibilia
- Language: English
- Number of Pages: Median: 110
- Publisher: ➤ Springer Basel - Springer - Springer Basel AG
- Publish Date: 2011 - 2013
- Publish Location: Basel
“Drugs for HER2-positive breast cancer” Subjects and Themes:
- Subjects: ➤ BRCA genes - Genes, erbB-2 - Cancer - Pharmacology - Monoclonal Antibodies - Gene therapy - Breast Neoplasms - Breast - Trastuzumab - Chemotherapy - Therapeutic use - Molecular Targeted Therapy - Antineoplastic Agents - Drug therapy - Methods - Cancer, treatment - Breast, cancer - Cancer, chemotherapy - Monoclonal antibodies - Antineoplastic agents - Genes
Edition Identifiers:
- The Open Library ID: OL35774763M - OL25006118M
- Online Computer Library Center (OCLC) ID: 706780796
- Library of Congress Control Number (LCCN): 2011286603
- All ISBNs: ➤ 3034600933 - 3034600941 - 9783034600941 - 9783034600934 - 3034803184 - 9783034803182
Access and General Info:
- First Year Published: 2011
- Is Full Text Available: No
- Is The Book Public: No
- Access Status: No_ebook
Online Marketplaces
Find Drugs for HER2-positive breast cancer at online marketplaces:
- Amazon: Audiable, Kindle and printed editions.
- Ebay: New & used books.
4Recombinant monoclonal antibody trastuzumab for the treatment of metastatic breast cancer with tumors overexpressing the HER2-neu proto-oncogene
By Marcus Oehlrich
“Recombinant monoclonal antibody trastuzumab for the treatment of metastatic breast cancer with tumors overexpressing the HER2-neu proto-oncogene” Metadata:
- Title: ➤ Recombinant monoclonal antibody trastuzumab for the treatment of metastatic breast cancer with tumors overexpressing the HER2-neu proto-oncogene
- Author: Marcus Oehlrich
- Language: English
- Number of Pages: Median: 109
- Publisher: dissertation.de
- Publish Date: 2003
- Publish Location: Berlin
“Recombinant monoclonal antibody trastuzumab for the treatment of metastatic breast cancer with tumors overexpressing the HER2-neu proto-oncogene” Subjects and Themes:
- Subjects: ➤ Breast - Cancer - Immunotherapy - Trastuzumab - Metastasis - HER-2 protein - HER-2 gene
Edition Identifiers:
- The Open Library ID: OL31620719M
- Library of Congress Control Number (LCCN): 2004425731
- All ISBNs: 9783898257541 - 3898257541
Access and General Info:
- First Year Published: 2003
- Is Full Text Available: No
- Is The Book Public: No
- Access Status: No_ebook
Online Marketplaces
Find Recombinant monoclonal antibody trastuzumab for the treatment of metastatic breast cancer with tumors overexpressing the HER2-neu proto-oncogene at online marketplaces:
- Amazon: Audiable, Kindle and printed editions.
- Ebay: New & used books.
Wiki
Source: Wikipedia
Wikipedia Results
Search Results from Wikipedia
Trastuzumab
Trastuzumab, sold under the brand name Herceptin among others, is a monoclonal antibody used to treat breast cancer and stomach cancer. It is specifically
Trastuzumab emtansine
Trastuzumab emtansine, sold under the brand name Kadcyla, is an antibody-drug conjugate consisting of the humanized monoclonal antibody trastuzumab (Herceptin)
Trastuzumab deruxtecan
Trastuzumab deruxtecan, sold under the brand name Enhertu, is an antibody-drug conjugate consisting of the humanized monoclonal antibody trastuzumab (Herceptin)
Pertuzumab/trastuzumab/hyaluronidase
Pertuzumab/trastuzumab/hyaluronidase, sold under the brand name Phesgo, is a fixed-dose combination medication to treat adults with HER2-positive breast
Pertuzumab
brand name Perjeta, is a monoclonal antibody used in combination with trastuzumab and docetaxel for the treatment of metastatic HER2-positive breast cancer;
Trastuzumab/hyaluronidase
Trastuzumab/hyaluronidase, sold under the brand name Herceptin SC among others, is a fixed-dose combination medication for the treatment of HER2-overexpressing
HER2
antibody trastuzumab (marketed as Herceptin). Trastuzumab is effective only in cancers where HER2 is over-expressed. One year of trastuzumab therapy is
Cancer immunotherapy
system. Examples of such antibodies include rituximab (targeting CD-20), trastuzumab (targeting HER-2), and cetuximab (targeting EGFR).[citation needed] Passive
Tucatinib
2021. Tucatinib is a kinase inhibitor indicated in combination with trastuzumab and capecitabine for the treatment of adults with advanced unresectable
Succinimidyl 4-(N-maleimidomethyl)cyclohexane-1-carboxylate
example, a targeted anticancer agent – trastuzumab emtansine (antibody-drug conjugate containing an antibody trastuzumab chemically linked to a highly potent